ARQT Q1 2021 Earnings — Arcutis Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ARQTArcutis Biotherapeutics, Inc.

$3B

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$178,000

Operating Income

-$36M

Net Income

-$36M

EPS (Diluted)

$-0.76

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$46M

Free Cash Flow

-$47M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$471M

Total Liabilities

$20M

Stockholders' Equity

$451M

Cash & Equivalents

$289M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$178,000	-$65,000	-173.8%
Operating Income	-$36M	-$29M	-25.9%
Net Income	-$36M	-$28M	-28.7%